HEXIS CAPITAL
MANAGEMENT
About Hexis

A highly experienced team. A focused mandate.

Combining deep expertise in equity and tobacco investment research with a strong track record in ETF strategy, distribution and institutional asset management across blue-chip firms.

60+
Years global tobacco sector research
50+
Years ETF strategy, launch & institutional distribution
100+
Combined years across the management team
Management team

The people behind Hexis.

PV

Pieter Vorster

Founder & Chief Executive Officer

30+ years in equity research (Credit Suisse & UBS) and asset management, including 20+ years focused on the global tobacco sector. Founder of Hexis and Idwala Research.

Credit SuisseUBSIdwala Research
JF

Jonathan Fell

Head of Research & Engagement

30+ years in equity research at Merrill Lynch, Morgan Stanley and Deutsche Bank focused on tobacco and consumer stocks, and asset management at Ash Park Capital, which he co-founded.

Merrill LynchMorgan StanleyDeutsche BankAsh Park Capital
JS

Jim Snow

Chief Operating Officer & Chief Compliance Officer

30+ years in asset management and ETF strategy (BlackRock, BNP Paribas Investment Partners, Barclays Wealth, JPMorgan AM) with senior experience across portfolio construction, systematic investing and institutional allocation.

BlackRockBNP Paribas IPBarclays WealthJPMorgan AM
JA

John Adu

Chief Business Officer

Nearly 20 years in ETF innovation and distribution, with leadership roles across global ETF platform development and capital markets at JPMorgan Asset Management, iShares and Source.

JPMorgan AMiSharesSource
Our Mission

From exclusion to engagement.

Many investors have historically excluded the tobacco sector despite its strong long-term return profile. We believe active engagement — supporting an accelerated industry shift towards less harmful alternatives — lays the ground for both improved public health outcomes and sustainably improved valuation multiples.

Independent Oversight

Harm Reduction Stewardship Council.

Our stewardship program will be overseen by a Harm Reduction Stewardship Council composed of experts in public health and industry transformations, chaired by Derek Yach, former head of the WHO's Tobacco Free Initiative.